[Research progress on influencing factors of allergic rhinitis in children]

X L Han1, X L Liu2

  • 1Graduate School of Inner Mongolia Medical University, Hohhot 010059, China.

Insights

Allergic rhinitis (AR) is rising in children, impacting their development and causing societal burdens. This study examines individual and external factors contributing to childhood AR for better prevention and treatment strategies.

Area of Science:

  • Pediatrics
  • Immunology
  • Environmental Health

Context:

  • Allergic rhinitis (AR) incidence is increasing globally, particularly in pediatric populations.
  • Childhood AR significantly affects development, learning, and quality of life, imposing substantial socioeconomic burdens.
  • Understanding the multifactorial nature of AR is crucial for effective management.

Purpose:

  • To explore the influence of individual factors (genetic polymorphisms, epigenetics, inflammation, microecology) on pediatric AR.
  • To review the impact of external factors (allergens, air pollution, infections, climate change) on childhood AR.
  • To enhance the understanding of pediatric AR and establish a foundation for prevention and treatment.

Summary:

  • Investigates individual factors including genetic predispositions, epigenetic modifications, inflammatory pathways, and gut microbiome alterations in pediatric allergic rhinitis.
  • Examines environmental triggers such as aeroallergens, air pollutants, infectious agents, immune system dynamics, and climatic variations contributing to AR.
  • Synthesizes current knowledge on the complex interplay of intrinsic and extrinsic elements driving the rise of AR in children.

Impact:

  • Provides a comprehensive overview of pediatric AR etiology, aiding clinicians and researchers.
  • Offers insights into potential targets for novel therapeutic interventions and preventative measures.
  • Contributes to public health strategies aimed at mitigating the growing burden of allergic rhinitis in children.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Allergic Reactions02:06

Allergic Reactions

Overview
27.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297